Carboplatin in clinical stage I seminoma: too much and too little at the same time
- PMID: 21282532
- DOI: 10.1200/JCO.2010.29.5055
Carboplatin in clinical stage I seminoma: too much and too little at the same time
Comment in
-
Misunderstanding regarding the carboplatin dose comparison in MRC TE19/EORTC 30982.J Clin Oncol. 2011 Nov 1;29(31):4211; author reply 4211-2. doi: 10.1200/JCO.2011.36.1840. Epub 2011 Sep 26. J Clin Oncol. 2011. PMID: 21947823 No abstract available.
-
Carboplatin in clinical stage I seminoma: a valuable option for patient management.J Clin Oncol. 2011 Nov 1;29(31):4210-1; author reply 4211-2. doi: 10.1200/JCO.2011.36.2434. Epub 2011 Sep 26. J Clin Oncol. 2011. PMID: 21947827 No abstract available.
Comment on
-
Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214).J Clin Oncol. 2011 Mar 10;29(8):957-62. doi: 10.1200/JCO.2009.26.4655. Epub 2011 Jan 31. J Clin Oncol. 2011. PMID: 21282539 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
